AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
Nature Medicine1998Vol. 4(1), pp. 72–77
Citations Over TimeTop 1% of 1998 papers
G A Donzella, Dominique Schols, Steven Lin, José A. Esté, Kirsten Nagashima, Paul J. Maddon, Graham P. Allaway, Thomas P. Sakmar, Geoffrey Henson, Erik De Clercq, John P. Moore
Related Papers
- → Advances of CCR5 antagonists: From small molecules to macromolecules(2020)47 cited
- → Chemokine receptor-5 (CCR5) is a receptor for the HIV entry inhibitor peptide T (DAPTA)(2005)38 cited
- CCR5 antagonists for the treatment of HIV.(2004)
- → Antiretroviral agents: Focus on Maraviroc for the Treatment of HIV-1-Infected Adults(2010)
- → Understanding the HIV co-receptor tropism assay(2013)